The role of individualised homoeopathic medicines in improving the quality of life in dementia
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Quality of life will be assessed by using Dementia Quality of Life.
研究概览
简要总结
AIM:
To evaluate the effectiveness of individualized Homoeopathic medicines inimprovingthe quality of life indementiapatients.
OBJECTIVES
To assess the impact of individualized Homoeopathic medicine on the quality of life in dementia patients.
To measure the changes in memory, emotional wellbeing, daily activities using DEMQOL questionnaire before and after treatment
To identify the most used Homoeopathic medicines for dementia
BACKGROUND AND JUSTIFICATION
Dementia is a progressive neurodegenerative disorder marked by a decline in cognitive function, memory, language, and the ability to perform everyday activities. It primarily affects the elderly population and is associated with a significant deterioration in quality of life both for the individual and their caregivers .Despite the availability of conventional pharmacological treatments, these often provide only symptomatic relief and are frequently accompanied by side effects, especially in elderly individuals with multiple comorbidities. While there is small scale studies have reported improvement in symptoms and over all wellbeing in dementia patients using individualized homoeopathic medicine, there is a lack of structured clinical evidence evaluating its impact on quality of life using validated scale like DEMQOL. This study aim to play a role on improving overall wellbeing in dementia patients.
METHODOLOGY
The study will be conducted with clinically diagnosed 40 cases of dementia will be selected based on inclusion and exclusion criteria for the study. Diagnostic screening will be done by Montreal Cognitive Assessment. The cases will be analyzed and the totality of symptoms will be erected based on Homoeopathic philosophy to arrive the suitable remedy for each patient. Then the individualized Homoeopathic medicine will be prescribed with the proper dose, potency, and repetitions. Follow up will be taken once in a month to assess the improvement in quality of life among dementia patients. Pre assessment and post assessment of Dementia Quality of Life DEMQOL will be taken three months once to evaluate the quality of life in dementia patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 46.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Age of the patient above 45 years.
- •Confirmed cases of dementia through Montreal Cognitive assessment.
- •Patient having MoCA score above 10 to 25.
排除标准
- •Patients having other neurological disorders like Alzheimer disease, Parkinsons disease.
- •Patients having other psychiatric illness like, Bipolar disorder, Schizophrenia etc.
- •Patients under allopathic medication such as anticholinergic and antipsychotic drugs Patients having serious systemic disorders.
结局指标
主要结局
Quality of life will be assessed by using Dementia Quality of Life.
时间窗: 3 months
Maximum score- 112
时间窗: 3 months
From baseline score: 1 to 9 score increases - Mild improvement.
时间窗: 3 months
10–19 score increases - Moderate improvement.
时间窗: 3 months
More than 20 score increases - Marked improvement
时间窗: 3 months
次要结局
未报告次要终点
研究者
Dr KALAIYARASI P
WHITE MEMORIAL HOMOEO MEDICAL COLLEGE AND HOSPITAL